➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Merck
Medtronic
Dow
McKesson

Last Updated: May 13, 2021

DrugPatentWatch Database Preview

Biocon Pharma Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for BIOCON PHARMA, and what generic and branded alternatives to BIOCON PHARMA drugs are available?

BIOCON PHARMA has four approved drugs.

There is one tentative approval on BIOCON PHARMA drugs.

Summary for Biocon Pharma

Drugs and US Patents for Biocon Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Biocon Pharma TACROLIMUS tacrolimus CAPSULE;ORAL 212297-003 Nov 10, 2020 AB RX No No   Get Started for $10   Get Started for $10
Biocon Pharma EVEROLIMUS everolimus TABLET;ORAL 214182-001 Feb 11, 2021 DISCN No No   Get Started for $10   Get Started for $10
Biocon Pharma PRAVASTATIN SODIUM pravastatin sodium TABLET;ORAL 209869-004 Apr 13, 2018 AB RX No No   Get Started for $10   Get Started for $10
Biocon Pharma TACROLIMUS tacrolimus CAPSULE;ORAL 212297-001 Nov 10, 2020 AB RX No No   Get Started for $10   Get Started for $10
Biocon Pharma PRAVASTATIN SODIUM pravastatin sodium TABLET;ORAL 209869-002 Apr 13, 2018 AB RX No No   Get Started for $10   Get Started for $10
Biocon Pharma SIMVASTATIN simvastatin TABLET;ORAL 078034-002 Dec 20, 2006 AB RX No No   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
McKesson
Baxter
Mallinckrodt
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.